Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease

by Jones PW
Published 2015-03-01

Highlights and hot topics in the management of COPD: where are we heading?

by Agustí A, Jones PW, Vogelmeier C
Published 2016-02-01

Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease

by Jones PW, Price D, van der Molen T
Published 2011-05-01

Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan

by Onishi K, Yoshimoto D, Hagan GW, Jones PW
Published 2014-05-01

Exacerbations of COPD

by Pavord ID, Jones PW, Burgel PR, Rabe KF
Published 2016-02-01

COPD: the patient perspective

by Jones PW, Watz H, Wouters EFM, Cazzola M
Published 2016-02-01

Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease

by Nishimura K, Nishimura T, Onishi K, Oga T, Hasegawa Y, Jones PW
Published 2014-02-01

COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure

by Bajaj MPK, Burrage DR, Tappouni A, Dodd JW, Jones PW, Baker EH
Published 2018-12-01

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

by Papi A, Jones PW, Dalvi PS, McAulay K, McIver T, Dissanayake S
Published 2015-11-01

Interpreting patient-reported outcomes from clinical trials in COPD: a discussion

by Jones PW, Rennard S, Tabberer M, Riley JH, Vahdati-Bolouri M, Barnes NC
Published 2016-12-01

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world

by Barnes N, Ishii T, Hizawa N, Midwinter D, James M, Hilton E, Jones PW
Published 2018-02-01

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany

by Lewis HB, Schroeder M, Gunsoy NB, Janssen EM, Llewellyn S, Doll HA, Jones PW, Ismaila AS
Published 2020-03-01

Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD

by Negewo NA, McDonald VM, Baines KJ, Wark PAB, Simpson JL, Jones PW, Gibson PG
Published 2016-07-01

A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011

by Betsuyaku T, Kato M, Fujimoto K, Hagan G, Kobayashi A, Hitosugi H, James M, Jones PW
Published 2013-10-01

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting

by Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK
Published 2019-05-01

A randomized trial of symptom-based management in Japanese patients with COPD

by Betsuyaku T, Kato M, Fujimoto K, Kobayashi A, Hayamizu T, Hitosugi H, Hagan G, James MH, Jones PW
Published 2018-08-01

Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function

by Spilling CA, Bajaj MPK, Burrage DR, Ruickbie S, Thai NJ, Baker EH, Jones PW, Barrick TR, Dodd JW
Published 2019-08-01

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

by Vogelmeier CF, Naya IP, Maltais F, Bjermer L, Kerwin EM, Tombs L, Jones PW, Compton C, Lipson DA, Boucot IH
Published 2021-05-01

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD

by Bourbeau J, Bafadhel M, Barnes NC, Compton C, Di Boscio V, Lipson DA, Jones PW, Martin N, Weiss G, Halpin DMG
Published 2021-03-01

Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Study

by Gil HI, Zo S, Jones PW, Kim BG, Kang N, Choi Y, Cho HK, Kang D, Cho J, Park HY, Shin SH
Published 2021-06-01